Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies
- PMID: 36902026
- PMCID: PMC10003426
- DOI: 10.3390/ijms24054596
Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies
Abstract
Demyelinating diseases are a group of pathologies characterized by the alteration of myelin-that is, the coating that wraps around most of the nerve fibres of the central and peripheral nervous system, whose goal is the improvement of nerve conduction and the preservation of energy spent during action potential propagation [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Special Issue “Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies”. [(accessed on 1 January 2020)];Int. J. Mol. Sci. Available online: https://www.mdpi.com/journal/ijms/special_issues/demyelinating_diseases. - PMC - PubMed